%0 Journal Article
%T Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR MutationŠ\Positive NonŠ\Small Cell Lung Cancer: A Prospective, SingleŠ\Arm, Phase II Study
%A Aiqin Gu
%A Baohui Han
%A Bo Jing
%A Chunlei Shi
%A Hao Bai
%A Heng Zhao
%A Hua Zhong
%A Huiming Wang
%A Jianxing Shi
%A Jiayuan Sun
%A Jie Shen
%A Jie Zhang
%A Junyi Ye
%A Junyuan Wang
%A Liwen Xiong
%A Liyan Jiang
%A Rong Li
%A Weiyan Zhang
%A Wentao Fang
%A Yuqing Lou
%J Archive of "The Oncologist".
%D 2019
%R 10.1634/theoncologist.2018-0120
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369937/